With this background, we have investigated IL-12R expression and function in human primary lung adenocarcinomas and the direct anti-tumor activity of IL-12 on NSCLC cells in vitro and in vivo, unraveling the molecular mechanisms involved. This evidence concerns the gene IL12RB1 and neoplasm.